AEM Early Access 58: Ketamine administration for acute painful sickle cell crisis: A randomized controlled trial

<p>The objective was to evaluate the efficacy and safety of single-dose ketamine infusion in adults with sickle cell disease (SCD) who presented with acute sickle vasoocclusive crisis (VOC).</p>